{"filings":[{"id":1196156,"accession_number":"0001193125-26-277605","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-06-22T20:40:27+00:00","items":["5.07"],"status":"ready","headline":"American Well stockholders re-elect Ido Schoenberg, ratify PwC, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class III director Dr. Ido Schoenberg elected with 20,509,462 votes for, 954,941 withheld, 2,507,946 broker non-votes.","Appointment of PricewaterhouseCoopers LLP as auditor for FY 2026 ratified: 23,945,239 for, 27,110 against, no broker non-votes.","Non-binding advisory vote on named executive officer compensation approved: 21,137,741 for, 326,662 against, 2,507,946 broker non-votes.","Dr. Roy Schoenberg did not stand for re-election as previously disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":23042,"accession_number":"0001193125-26-218277","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-05-12T12:44:22+00:00","items":["5.02"],"status":"ready","headline":"Co-founder and EVP Chairman Roy Schoenberg resigns from board effective May 6, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Roy Schoenberg resigned as Board member and Executive Vice Chairman effective May 6, 2026.","Resignation due to new employment opportunity; not related to any disagreement with company.","Schoenberg was a co-founder and served for nearly twenty years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92591,"accession_number":"0001193125-26-206427","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell beats Q1 revenue guidance at $54.9M; net loss narrows to $10.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $54.9M exceeds guidance; subscription $24.9M, AMG visit revenue $28.9M.","Net loss improved to ($10.3M) from ($25.2M) in Q4 2025; gross margin 51%.","Adjusted EBITDA loss narrowed to ($3.1M) from ($10.3M) in Q4 2025.","FY2026 guidance reaffirmed: revenue $195-205M, Adj EBITDA ($16M)-($12M); Q2 rev $48-52M.","Reiterates goal of positive cash flow from operations in Q4 2026."],"consensus_eps_estimate":-1.1815,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":54883000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92590,"accession_number":"0001193125-26-140460","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Dr. Peter Slavin to resign from American Well board at 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Peter Slavin notified resignation from Board, effective at next annual meeting in 2026.","Resignation due to his transition to a new role on the West Coast, not due to any disagreement with the Company.","He will continue serving as director until the effective date of the annual meeting.","Dr. Slavin served over nine years; Company expressed gratitude for his service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103541,"accession_number":"0001193125-26-048737","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Q4 revenue $55.3M beat guidance; net loss narrows; FY 2026 EBITDA guided lower but cash flow breakeven targeted","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $55.3M exceeded guidance; subscription rev $28.8M, AMG visit rev $23.7M.","Q4 net loss ($25.2M) vs ($31.9M) Q3; Adj EBITDA ($10.3M) vs ($12.7M) Q3.","FY 2025 revenue $249.3M; net loss ($95.0M) vs ($212.6M) 2024; Adj EBITDA ($39.9M) vs ($134.4M).","2026 guidance: rev $195-205M, Adj EBITDA ($24M)-($18M); targets cash flow breakeven in Q4 2026.","Cash and short-term securities $182.3M at year-end."],"consensus_eps_estimate":-1.8136,"consensus_eps_actual":-5.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":249325000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103540,"accession_number":"0001193125-26-007807","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"American Well extends digital care platform partnership with Elevance through Jan 2029","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered 3-year Amended SOW effective Jan 1, 2026, replacing prior 2023 agreement with Elevance Health.","Elevance pays annual subscription fees; may also engage for professional, development, and marketing services.","Term runs Jan 1, 2026 to Jan 1, 2029, with automatic one-year renewals unless terminated.","Elevance can terminate at convenience on 365 days' notice; both parties can terminate for material breach after cure.","White-labeled LiveHealth Online platform continues to be operated by American Well on behalf of Elevance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103539,"accession_number":"0001193125-26-001087","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2026-01-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Amwell extends Elevance Health partnership to 2029; adds AI provision","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Master Services Agreement extended through Jan 1, 2029, auto-renewing annually thereafter.","New 3-year Healthy Impact SOW (Jan 2026–Jan 2029) with time-and-materials professional services.","Clinical provider agreements with Elevance affiliates extended to Jan 1, 2029.","Amends AI governance: parties to negotiate AI terms within 90 days subject to Elevance committee approval.","Elevance can terminate for convenience on 365 days' notice; termination triggers continuity-of-care obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119794,"accession_number":"0001193125-25-264710","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q3 revenue $56.3M beats guidance; net loss widens to $31.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $56.3M (subscription $30.9M, AMG visits $21.2M) exceeded prior Q2 guidance.","Net loss ($31.9M) vs ($19.5M) in Q2; Adjusted EBITDA ($12.7M) vs ($4.7M) sequentially.","Total visits 1.1 million in Q3.","FY2025 revenue guidance narrowed to $245M-$248M; Adj EBITDA to ($45M)-($42M).","Q4 revenue guidance $51M-$54M with Adj EBITDA ($15M)-($12M); reaffirmed 2026 cash flow breakeven."],"consensus_eps_estimate":-1.8343,"consensus_eps_actual":-4.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":194017000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136360,"accession_number":"0000950170-25-103029","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q2 revenue $70.9M, net loss $19.5M; cuts FY2025 revenue guidance to $245M-$250M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $70.9M (subscription $40.4M, AMG visits $22.8M); gross margin 56.1%.","Net loss $19.5M (vs $18.4M Q1); Adj. EBITDA loss improved to $4.7M from $12.2M Q1.","Added Florida Blue health plan; extended US Defense Health Agency contract.","FY2025 revenue guidance lowered to $245M-$250M from $250M-$260M; Adj. EBITDA narrowed to ($50M)-($45M).","Q3 2025 guidance: revenue $53M-$56M, Adj. EBITDA loss ($15M)-($13M)."],"consensus_eps_estimate":-1.7763,"consensus_eps_actual":-2.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":137731000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153491,"accession_number":"0000950170-25-087478","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-06-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"American Well Shareholders Elect Directors, Ratify PwC, and Approve Executive Compensation at 2025 Meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director Stephen Schlegel elected with 18,018,064 votes for and 2,216,772 withheld.","Director Delos Cosgrove elected with 18,243,841 votes for and 1,990,995 withheld.","Director Rivka Goldwasser elected with 18,210,793 votes for and 2,024,043 withheld.","Ratification of PricewaterhouseCoopers as auditor approved with 22,756,163 for and 19,373 against.","Advisory vote on executive compensation approved with 19,633,851 for and 600,985 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153490,"accession_number":"0000950170-25-061838","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q1 2025 revenue $66.8M; net loss narrows to $18.4M vs $44.6M prior quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $66.8M (subscription $32.2M, AMG visits $26.6M); gross margin 53%.","Net loss ($18.4M) improved from ($44.6M) in Q4 2024; adjusted EBITDA ($12.2M) vs ($22.8M) prior quarter.","Total visits 1.3M; reiterated FY2025 guidance: revenue $250-260M, adjusted EBITDA ($55M)-($45M).","Q2 2025 guidance: revenue $62-67M, adjusted EBITDA ($12)-($10)M.","Management targets positive cash flow from operations in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":66833000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172224,"accession_number":"0000950170-25-030996","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Amwell appoints Dan Zamansky as CPTO; Vaughn Paunovich departs March 2, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dan Zamansky named chief product and technology officer, effective March 3, 2025.","Zamansky joins from Amazon, where he led AWS Health AI and product/tech teams.","Vaughn Paunovich's employment ends March 2, 2025; receives severance including 70% base salary bonus.","Paunovich guided re-platforming effort; CEO Ido Schoenberg thanked him for contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172223,"accession_number":"0000950170-25-018843","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q4 revenue $71M, net loss $44.6M; FY2025 revenue guidance $250-260M, adj EBITDA -$45 to -$55M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024: total revenue $71.0M (subscr $36.9M, AMG visits $29.2M), gross margin 48%.","Q4 net loss $44.6M; adj EBITDA -$22.8M, improving from -$31.0M in Q3 2024.","Full-year 2024: revenue $254.4M, net loss $212.6M, adj EBITDA -$134.4M; total visits 5.9M.","FY2025 guidance: revenue $250-260M, adj EBITDA -$55M to -$45M; Q1 rev $59-61M, adj EBITDA -$18 to -$20M.","Cash & short-term securities $228.3M at year-end; targeting positive cash flow in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-13.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":254364000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172222,"accession_number":"0000950170-25-004254","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Amwell sells telepsychiatry business to Avel eCare for $21M cash plus earn-out","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Upfront cash $20.7M (1.1x trailing 12-month revenue) plus earn-out of 0.4x next 12-month revenues.","Sale closed Jan 8; includes APC technology, personnel, Asana network. Reiterates FY2024 revenue guidance $247-252M.","Reiterates positive cash flow goal in 2026. Pro forma shows ~$24M annual revenue removed and ~$10.4M estimated gain on sale.","Pro forma for 9 months to Sep 30, 2024: net loss improved from $(165.5M) to $(164.0M), EPS from $(11.13) to $(11.03)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189205,"accession_number":"0000950170-24-137929","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Amwell CFO Mark Hirschhorn adds COO role; two senior executives depart","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Hirschhorn to serve as both CFO and COO effective Jan. 1, 2025; salary increased to $575,000, bonus target 125%.","Kathy Weiler (Chief Commercial & Growth Officer) to depart Dec. 31, 2024; will receive 2024 target bonus in lump sum.","COO Kurt Knight also departing at year-end after 14-year tenure; no separation details provided.","Hirschhorn's 2024 annual bonus set at $500,000 per amendment filed.","Company reiterates confidence in path to cash flow positive in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189204,"accession_number":"0000950170-24-119621","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"American Well adopts inducement plan, grants $2.5M RSU and $5M LTIP to new CFO Hirschhorn","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["2024 Inducement Plan adopted effective Nov 4, 2024; 1,222,960 shares reserved for inducement awards.","New CFO Mark Hirschhorn receives RSU award with grant date value $2.5M; 25% vests on grant date, rest over 3 years.","Additional $5M long-term incentive award (LTIP) subject to EBITDA and valuation targets, vesting over 4 years.","Awards vest on termination without cause/good reason (1 yr) and fully upon change in control within 24 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189203,"accession_number":"0000950170-24-118987","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q3 2024: Revenue $61M, net loss $44M; guidance cut on revenue and visits, EBITDA outlook narrowed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $61.0M (subscription $26.2M, AMG visit revenue $27.5M); gross margin 37%.","Net loss ($44.0M) vs ($49.9M) in Q2; Adjusted EBITDA ($31.0M) vs ($35.0M) in Q2.","Total visits 1.4M, ~70% on Converge platform.","FY2024 guidance revised: revenue $247-252M (from $259-269M); AMG visits 1.4-1.5M (from 1.6-1.7M).","Adjusted EBITDA guidance improved to ($137)-($142)M from ($150)-($145)M."],"consensus_eps_estimate":null,"consensus_eps_actual":-11.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":183358000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189202,"accession_number":"0000950170-24-114765","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Amwell CFO Robert Shepardson resigns; Mark Hirschhorn appointed CFO effective Oct 21","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shepardson resigns effective Oct 18, 2024; no disagreement with company operations.","Hirschhorn, former CEO of TapestryHealth and Teladoc CFO/COO, becomes CFO Oct 21.","Hirschhorn receives base salary $485,000, target bonus 100%, and $500,000 signing bonus.","RSU grant of $2.5M (25% vests at grant, 75% over 3 years) plus additional LTI up to $5M.","Hirschhorn to oversee financial operations and capital allocation; company cites path to profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205703,"accession_number":"0000950170-24-099877","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"American Well amends CCO Weiler's contract; adds severance for voluntary exit after June 2025","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CCO Weiler gets one-year base salary severance, pro-rata bonus, and equity vest continuation if she voluntarily resigns without Good Reason after June 1, 2025.","Company also reimbursed Weiler up to $15,000 in legal fees for negotiating the amendment.","Amendment effective August 16, 2024; new severance terms apply only if she does not accept a new position prior to termination.","The equity vesting provision accelerates unvested awards that would have vested in the first year after termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205702,"accession_number":"0000950170-24-088603","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q2 2024 revenue $62.8M, net loss $49.9M; narrows FY adjusted EBITDA loss guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $62.8M, subscription $27.5M, AMG visit revenue $28.7M; gross margin 37%.","Net loss $49.9M vs $73.4M in Q1; adjusted EBITDA -$35.0M vs -$45.7M sequentially.","Total visits 1.5M, ~70% on Converge platform.","FY 2024 adjusted EBITDA guidance improved to ($150M-$145M) from ($160M-$155M); revenue reaffirmed at $259-269M."],"consensus_eps_estimate":null,"consensus_eps_actual":-8.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":122312000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205701,"accession_number":"0000950170-24-083685","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"American Well (AMWL) effects 1-for-20 reverse stock split effective July 10, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1-for-20 ratio executed on July 10, 2024 at 5:00 p.m. ET.","Class A common stock began trading on split-adjusted basis July 11; symbol unchanged (AMWL).","New CUSIP for Class A common stock post-split: 03044L 204.","Certificate of Amendment to Amended and Restated Certificate of Incorporation filed as Exhibit 3.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205700,"accession_number":"0000950170-24-079161","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Amwell announces 1-for-20 reverse stock split to regain NYSE compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved 1-for-20 reverse split effective July 10, 2024; trading begins July 11 under AMWL.","Class A shares reduce from ~266M to ~13.3M; new CUSIP 03044L 204.","CFO Shepardson: split aims to meet NYSE $1.00 minimum closing price requirement.","Shareholders authorized split at June 18 meeting; no fractional shares will be issued."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222639,"accession_number":"0000950170-24-076909","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"American Well shareholders elect three Class I directors, approve reverse stock split","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Derek Ross, Deborah Jackson, Rob Webb elected as Class I directors for terms expiring 2027.","Ratified PwC as independent auditor for FY2024 (426.6M for, 0.8M against).","Non-binding advisory vote approved NEO compensation (384.5M for, 7.8M against).","Approved reverse stock split amendment (424.2M for, 2.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222638,"accession_number":"0000950170-24-074353","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-06-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Amwell appoints former Morgan Stanley MD Ricky Goldwasser to board, replacing Deval Patrick","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Goldwasser appointed as Class II director effective June 13, 2024; term ends at 2025 annual meeting.","She qualifies as independent under NYSE rules and will serve on the Audit Committee.","Goldwasser spent 15 years at Morgan Stanley as MD, head of US Healthcare Services & Technology Research and Investment Banking.","She replaces Deval Patrick, who served on the board since 2015 and helped guide the company through its 2020 IPO.","Eligible for standard non-employee director compensation as previously disclosed in the company's Q1 2024 Form 10-Q."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222637,"accession_number":"0000950170-24-073146","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-06-13T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Amwell co-CEO Roy Schoenberg becomes Executive Vice Chairman; Ido Schoenberg sole CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Roy Schoenberg resigned as President & Co-CEO effective June 13, 2024, appointed Executive Vice Chairman.","Ido Schoenberg assumes role of sole Chief Executive Officer.","Roy Schoenberg receives $325k base salary, 150% target bonus, and $1.95M transition benefits with equity acceleration (excluding PSUs).","Non-competition and non-solicitation restrictions apply for 24 months post-termination.","Resignation involved no disagreement with company operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222636,"accession_number":"0000950170-24-051284","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q1 2024 revenue $59.5M, net loss widens to $73.4M; guides 2025 rev $335-350M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue of $59.5M (subscription $24.9M, AMG visit revenue $31.1M); gross margin 31%.","Net loss $73.4M vs $50.0M in Q4 2023; adjusted EBITDA loss $45.7M vs $36.9M.","Total visits 1.7M; 68% on Converge platform; key MHS deployment milestone noted.","Reiterates 2024 guidance: rev $259-269M, adj EBITDA loss $160-155M.","Preliminary 2025 view: rev $335-350M, adj EBITDA loss $45-35M; targeting breakeven in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":59522000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222635,"accession_number":"0000950170-24-041830","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-04-04T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"American Well (AMWL) receives NYSE delisting notice for non-compliance with $1 minimum bid price","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On April 2, 2024, received NYSE notice that average closing price of AMWL common stock was below $1 per share over 30 consecutive trading-days.","No immediate delisting; six-month cure period beginning April 2 to regain compliance.","Company plans to regain compliance through a reverse stock split, subject to board and stockholder approval at its 2024 annual meeting.","The notice does not affect business operations, SEC reporting obligations, or continued NYSE trading during cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242158,"accession_number":"0000950170-24-015232","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q4 revenue $70.7M; net loss narrows to $50M; guides to 2026 EBITDA breakeven","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 total revenue $70.7M (subscription $27.3M, AMG visits $32.1M); gross margin 34%.","Q4 net loss $50.0M vs Q3 $137.1M (Q3 included $78.9M goodwill impairment); adjusted EBITDA -$36.9M.","Full-year 2023 revenue $259M; net loss $679.2M (includes $436.5M goodwill impairment); adj. EBITDA -$165.4M.","FY2024 guidance: revenue $259-269M, AMG visits 1.6-1.7M, adj. EBITDA -$160M to -$155M.","Preliminary FY2025: revenue $335-350M, adj. EBITDA -$45M to -$35M; target adj. EBITDA breakeven by 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":259047000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259555,"accession_number":"0000950170-23-073092","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-12-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Deval Patrick to resign from American Well board effective 2024 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Deval Patrick notified resignation from Board effective date of next annual meeting in 2024.","Resignation due to new role limiting outside board participation; not due to any disagreement.","He served over eight years on the Board and will continue serving until the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259554,"accession_number":"0000950170-23-057440","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q3 revenue $61.9M, net loss $137.1M includes $78.9M goodwill impairment; guidance revised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $61.9M (subscription $28.4M, AMG visit revenue $26.7M); gross margin 35%.","Net loss $137.1M vs. $93.5M in Q2 2023, primarily from $78.9M non-cash goodwill impairment.","Adjusted EBITDA improved to ($38.5M) from ($45.3M) in Q2; cash and short-term securities $418.1M.","Total visits 1.4M; Converge platform visits reached 50% of total vs. 43% in Q2.","2023 guidance: revenue $257-263M; Adjusted EBITDA now ($162M) to ($167M), reflecting Defense Health Agency win investment."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":188370000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276816,"accession_number":"0000950170-23-037175","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q2 revenue $62.4M, net loss $93.5M; cuts FY revenue guidance to $257-263M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $62.4M ($28.0M subscription, $28.1M AMG visits); gross margin 39%.","Net loss $93.5M includes $27.3M non-cash goodwill impairment; Adj. EBITDA ($45.3M).","FY 2023 revenue guidance cut to $257-263M from $275-285M; Adj. EBITDA now ($160)-($165)M.","Total visits 1.5M; Converge platform visits grew to 43% of total from 36% Q1.","Cash and short-term securities $458.7M at quarter-end."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":126448000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294633,"accession_number":"0000950170-23-030204","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-06-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"American Well shareholders elect three Class III directors, ratify PwC, approve say-on-pay at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Peter Slavin, Dr. Ido Schoenberg, Dr. Roy Schoenberg elected as Class III directors with >335M votes each.","Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2023: 400.9M for, 1.1M against.","Advisory vote on named executive officer compensation approved: 343.9M for, 34.8M against, 23.3M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294632,"accession_number":"0000950170-23-017192","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q1 revenue $64M; net loss $398.5M with $330.3M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $64.0M (subscription $28.7M, AMG visits $32.5M); gross margin 39.5%.","Net loss ($398.5M) vs ($61.6M) in Q4 2022; includes $330.3M non-cash goodwill impairment.","Adjusted EBITDA ($44.6M) vs ($43.4M) in prior quarter.","Total visits 1.7M; Converge platform visits grew to 36% of total (from 28% in Q4 2022).","FY 2023 guidance reaffirmed: revenue $275-285M, Adj. EBITDA ($150M)-($160M)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":64001000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":315236,"accession_number":"0000950170-23-003787","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q4 revenue $79.2M (+9% YoY); full-year net loss widens to $272.1M; 2023 guidance below 2022 revenue","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 revenue $79.2M, up 9% YoY; subscription revenue $30.7M, AMG visit revenue $35.1M.","Q4 net loss ($61.6M) improved from ($70.6M) in Q3 2022; adjusted EBITDA ($43.4M).","Full-year 2022 revenue $277.2M (+10% YoY); net loss $272.1M vs $176.8M in 2021.","Full-year adjusted EBITDA ($175.3M) vs ($122.7M) in 2021; cash and securities $538.5M.","2023 outlook: revenue $275-285M, AMG visits 1.45-1.65M, adjusted EBITDA ($150)-($160)M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":277190000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":333571,"accession_number":"0000950170-22-025908","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-12-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"American Well enters 3-year agreement with Elevance Health to continue LiveHealth Online platform services","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["MSA and related provider agreements effective Jan 1, 2023; initial 3-year term through Dec 31, 2025.","Elevance Health to pay annual subscription and Per Member Per Month fees; potential professional services fees.","Provider agreements with Online Care Group ensure 50-state clinician network for digital consultations via LiveHealth Online.","Agreements auto-renew for successive one-year terms; either party may terminate for material breach, change-of-control, or bankruptcy.","Supersedes the prior Amended and Restated Vendor Agreement dated Dec 23, 2014."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":333570,"accession_number":"0000950170-22-022630","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell reports Q3 revenue $69.2M, net loss $70.6M; narrows adjusted EBITDA guidance to ($180)M-($190)M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $69.2M, up 11% YoY; subscription revenue $31.9M, up 19% YoY.","Net loss of $70.6M, roughly flat vs Q2 2022's $69.7M net loss.","Adjusted EBITDA improved to ($41.9)M from ($42.8)M in Q2; FY2022 guidance narrowed to ($180)M-($190)M, $10M better.","Revenue expected at lower end of $275M-$285M range; AMG visits guided to 1.4-1.5 million; active providers up 23% to 98,500."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":197957000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":333569,"accession_number":"0000950170-22-021924","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-11-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Amwell appoints Robert Webb to Board of Directors effective October 31, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Webb appointed as Class I director; term ends at 2024 annual meeting.","Webb former CEO of Optum's consumer business and President of UnitedHealth Group Ventures.","Independent director per NYSE standards; no material transactions with Amwell.","Brings over 30 years of health tech leadership; eligible for non-employee director compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":351055,"accession_number":"0000950170-22-017011","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-08-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"American Well promotes CFO, COO, and international president to EVP roles; adds severance protections","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Robert Shepardson title changed to EVP and CFO; severance: unvested equity vests through first anniversary of termination.","COO Kurt Knight title changed to EVP and COO; severance: unvested equity vests through first anniversary of termination.","Phyllis Gotlib title changed to EVP and President, American Well International; same severance enhancement.","All amendments dated August 9, 2022; existing agreements otherwise unchanged.","Shepardson and Knight amendments govern U.S. employment; Gotlib amendment is through Israeli branch."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":351054,"accession_number":"0000950170-22-014766","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q2 revenue $64.5M (+7% YoY); adjusted EBITDA loss narrows to $42.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $64.5M (+7% YoY); subscription $29.6M (+10%), AMG visits $29.7M (+8%).","Adjusted EBITDA loss of $42.8M improved from $47.1M in Q1 2022.","Active providers 103,500 (+46% YoY); total visits 1.5M (+19% YoY).","Cash and short-term securities $630.1M as of June 30, 2022.","Reiterates FY2022 outlook: revenue $275-285M, adjusted EBITDA ($200M)-($190M)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":128748000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368302,"accession_number":"0000950170-22-011692","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-06-15T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"American Well stockholders elect three Class II directors and ratify PwC as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected Deval Patrick (321.5M for), Stephen Schlegel (316.0M for), and Toby Cosgrove (330.3M for) as Class II directors.","Ratified PricewaterhouseCoopers LLP as independent auditor for FY2022 with 368.7M votes for.","Advisory vote on executive compensation frequency: 1 year recommended with 341.6M votes; company will hold annual advisory votes.","Broker non-votes were 26.7M for director elections and compensation proposal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368301,"accession_number":"0000950170-22-010670","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-05-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"American Well Chief Commercial & Growth Officer Brendan O'Grady resigns effective June 3, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brendan O'Grady resigns as Chief Commercial & Growth Officer, effective June 3, 2022.","No successor named in the filing; transition plan not disclosed.","Resignation announced on May 19, 2022, with two-week notice period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368300,"accession_number":"0001193125-22-154536","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"American Well grants co-CEOs PSUs of 1M target shares each, tied to market cap milestones up to 750%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Each co-CEO (Ido Schoenberg, Roy Schoenberg) receives 1M target PSUs; maximum payout 7.5M shares at 500% market cap growth.","PSUs vest over 3 years; 0% to 750% earned based on sustained market cap from 133% to 500% of grant-date value.","As condition, co-CEOs waive any other equity awards for 3 years from grant date (May 16, 2022).","Performance period runs May 16, 2022 to May 16, 2025; unearned PSUs cancelled after period.","Grants approved by Board and Compensation Committee, designed to drive long-term shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368299,"accession_number":"0000950170-22-010187","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-05-17T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"American Well issues 4.96M shares to former SilverCloud shareholders in lieu of earn-out","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 4,959,856 shares of Class A common stock to former SilverCloud shareholders in lieu of earn-out payment.","Shares issued under Section 4(a)(2) of the Securities Act; no general solicitation or advertising.","Amendment executed May 11, 2022, modifying original July 2021 merger agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368298,"accession_number":"0000950170-22-008503","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q1 revenue up 11% to $64.2M; net loss widens to $70.3M vs $39.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $64.2M (+11% YoY); subscription $28.7M, visit $30.7M.","Gross margin improved to 42.8% from 38.0%.","Net loss ($70.3M) vs ($39.8M); Adjusted EBITDA ($47.1M) vs ($26.4M).","Active providers ~102,000; visits ~1.8M, both up sequentially.","Reiterates FY2022 guidance: revenue $275-$285M; Adj. EBITDA ($200M)-($190M)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":64232000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368297,"accession_number":"0001193125-22-105707","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-04-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"American Well enters new employment agreement with President of International, Phyllis Gotlib","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual salary of $485,000, with 10% designated as special compensation for non-compete/confidentiality.","Target annual cash bonus of 100% of base salary; eligible for equity grants under 2020 plan.","Severance: 1x base salary paid over 12 months upon qualifying termination; equity acceleration near change in control.","Non-compete and non-solicitation restrictions apply for 12 months post-termination.","Agreement replaces prior contract dated Jan 1, 2018, effective April 8, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":387630,"accession_number":"0001193125-22-068084","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-03-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"American Well grants $2.1M PSUs each to three named execs under new market-cap-based LTI program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Named execs (Gotlib, Knight, Shepardson) each granted $2.1M in PSUs tied to market cap milestones; vesting 2022-2025.","70% of annual LTI for named officers (excl. Schoenbergs) shifted to PSUs; remaining 30% stays as time-vesting RSUs.","PSUs can earn 0-300% based on sustained 30-day average market cap growth vs. grant date; forfeited if unearned by Feb 2025.","Co-CEOs Ido & Roy Schoenberg may receive PSU grants later in 2022; no further details disclosed yet.","Plan effective March 1, 2022; designed to align exec compensation with long-term shareholder value creation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":387629,"accession_number":"0001193125-22-052085","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2022-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"American Well Corp reports Q4 and full year 2021 results, provides 2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2021 revenue $72.8M, up from $60.4M in Q4 2020; full year revenue $252.8M vs $245.3M.","Full year net loss $176.8M, improved from $228.6M loss in 2020; adjusted EBITDA ($122.7M).","Active providers reached ~91,000 at year-end 2021, up from ~72,000 a year earlier.","2022 guidance: revenue between $275M and $285M; adjusted EBITDA between ($200M) and ($190M).","Subscription revenue rose to $108.3M in 2021 from $98.4M; visit revenue $116.6M vs $117.2M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":252789000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":405588,"accession_number":"0001193125-21-325987","cik":1393584,"company_name":"American Well Corp","ticker":"AMWL","form_type":"8-K","filed_at":"2021-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Amwell Q3 revenue $62.2M, net loss improves to $50.9M; guides 2021 revenue lower, EBITDA higher","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $62.2M vs $62.6M YoY; subscription revenue $26.7M (+3.5%), visit revenue $30.0M (+5.3%).","Gross margin 43.5% vs 32.7% YoY; net loss ($50.9M) vs ($64.6M); Adj. EBITDA loss ($31.5M) vs ($26.2M).","Total visits ~1.4M (up from 1.3M Q2); active providers ~80,000 (vs 71,000 Q2, 62,000 YoY).","Narrows 2021 revenue guidance to $246-253M from $252-262M; lowers EBITDA loss guidance to ($143)-($136)M from ($154)-($146)M.","Converge platform development on track; added Conversa Health and SilverCloud Health capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":180039000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":153383882.53846157,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}